Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2021

22.09.2021 | Research Article

Patient values and preferences on polypharmacy and deprescribing: a scoping review

verfasst von: Evan Forest, Melissa Ireland, Uma Yakandawala, Teresa Cavett, Lalitha Raman-Wilms, Jamie Falk, Diana McMillan, Rhys Linthorst, Leanne Kosowan, Lisa Labine, Christine Leong

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background Understanding how patient values and preferences towards polypharmacy and deprescribing have been studied is important to gain insight on current knowledge in this area and to identify knowledge gaps. Aim To describe methods and outcomes for studying patient values and preferences towards polypharmacy and deprescribing, and to identify gaps in the existing literature. Method A scoping review was conducted on English-language studies that examined patient preferences and values related to polypharmacy and/or deprescribing among community-dwelling adults. MEDLINE, Embase, PubMed, PsycINFO, EconLit, Social Science Citation Index, Science Citation Index Expanded, International Pharmaceutical Abstracts, and CINAHL/AgeLine were searched. Results Thirty articles were included. Surveys (n = 17, 56.7%), interviews/focus groups (n = 9, 30.0%), and mixed methods (n = 3, 10.0%), were commonly used methods. Patients Attitudes Towards Deprescribing (PATD) was the most common tool used (n = 9, 30.0%). Twelve themes related to attitudes, social pressure, and control of polypharmacy/deprescribing were identified. The most frequently-encountered themes included desire or willingness to reduce medication load and influence of healthcare provider on medication use. Conclusion PATD was commonly used to assess preferences and values towards polypharmacy and limited knowledge on patient-important outcomes were addressed. Future research should focus on shared decision-making and communicating risk versus benefit of medications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.PubMed Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.PubMed
2.
Zurück zum Zitat Cantlay A, Glyn T, Barton N. Polypharmacy in the elderly. InnovAiT. 2016;9(2):69–77. Cantlay A, Glyn T, Barton N. Polypharmacy in the elderly. InnovAiT. 2016;9(2):69–77.
4.
Zurück zum Zitat Reason B, Terner M, Moses McKeag A, Tipper B, Webster G. The impact of polypharmacy on the health of Canadian seniors. Fam Pract. 2012;29(4):427–32.PubMed Reason B, Terner M, Moses McKeag A, Tipper B, Webster G. The impact of polypharmacy on the health of Canadian seniors. Fam Pract. 2012;29(4):427–32.PubMed
5.
Zurück zum Zitat Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.
6.
Zurück zum Zitat O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44(2):213–8.PubMedPubMedCentral O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44(2):213–8.PubMedPubMedCentral
7.
Zurück zum Zitat Bruyere Research Institute Deprescribing Guidelines Research Team. Deprescribing Guidelines and Algorithms. Available: deprescribing.org. Accessed 2 July 2021. Bruyere Research Institute Deprescribing Guidelines Research Team. Deprescribing Guidelines and Algorithms. Available: deprescribing.org. Accessed 2 July 2021.
8.
Zurück zum Zitat Institute of Medicine (US) Committee on Quality of Health Care in America, Crossing the quality chasm: a new health system for the 21st century, National Academies Press; 2001. Institute of Medicine (US) Committee on Quality of Health Care in America, Crossing the quality chasm: a new health system for the 21st century, National Academies Press; 2001.
9.
Zurück zum Zitat National Institute for Health and Care Excellence (NICE) 2021. Standards framework for shared-decision-making support tools, including patient decisión aids (ECD8). Published 17 June 2021. Available: www.nice.org/uk/corporate/ecd8. Accessed 13 July 2021. National Institute for Health and Care Excellence (NICE) 2021. Standards framework for shared-decision-making support tools, including patient decisión aids (ECD8). Published 17 June 2021. Available: www.​nice.​org/​uk/​corporate/​ecd8. Accessed 13 July 2021.
10.
Zurück zum Zitat Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review. Patient Educ Couns. 2016;99:491–500.PubMed Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review. Patient Educ Couns. 2016;99:491–500.PubMed
11.
Zurück zum Zitat Llewellyn-Thomas HA, Crump RT. Decision support for patients values clarification and preference elicitation. Med Care Res Rev. 2013;70(1 suppl):50S-79S.PubMed Llewellyn-Thomas HA, Crump RT. Decision support for patients values clarification and preference elicitation. Med Care Res Rev. 2013;70(1 suppl):50S-79S.PubMed
12.
Zurück zum Zitat Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
14.
Zurück zum Zitat Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.PubMed Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.PubMed
15.
Zurück zum Zitat Rich A, Brandes K, Mullan B, Hagger MS. Theory of planned behavior and adherence in chronic illness: a meta-analysis. J Behav Med. 2015;38:673–88.PubMed Rich A, Brandes K, Mullan B, Hagger MS. Theory of planned behavior and adherence in chronic illness: a meta-analysis. J Behav Med. 2015;38:673–88.PubMed
16.
Zurück zum Zitat Martin P, Tannenbaum C. A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial. BMJ Open. 2017;7(4):e015959.PubMedPubMedCentral Martin P, Tannenbaum C. A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial. BMJ Open. 2017;7(4):e015959.PubMedPubMedCentral
17.
Zurück zum Zitat Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002;48(1):87–91.PubMed Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002;48(1):87–91.PubMed
18.
Zurück zum Zitat Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–7.PubMed Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–7.PubMed
19.
Zurück zum Zitat Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803.PubMed Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803.PubMed
20.
Zurück zum Zitat Tegegn HG, Tefera YG, Erku DA, Haile KT, Abebe TB, Chekol F, et al. Older patients’ perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ Open. 2018;8(4):020590. Tegegn HG, Tefera YG, Erku DA, Haile KT, Abebe TB, Chekol F, et al. Older patients’ perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ Open. 2018;8(4):020590.
21.
Zurück zum Zitat Kovačević SV, Miljković B, Vučićević K, Ćulafić M, Kovačević M, Golubović B, et al. Elderly polypharmacy patients’ needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model. Patient Educ Couns. 2017;100(9):1714–9.PubMed Kovačević SV, Miljković B, Vučićević K, Ćulafić M, Kovačević M, Golubović B, et al. Elderly polypharmacy patients’ needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model. Patient Educ Couns. 2017;100(9):1714–9.PubMed
22.
Zurück zum Zitat Schiøtz ML, Frølich A, Jensen AK, Reuther L, Perrild H, Petersen TS, et al. Polypharmacy and medication deprescribing: a survey among multimorbid older adults in Denmark. Pharmacol Res Perspect. 2018;6(6):e00431.PubMedPubMedCentral Schiøtz ML, Frølich A, Jensen AK, Reuther L, Perrild H, Petersen TS, et al. Polypharmacy and medication deprescribing: a survey among multimorbid older adults in Denmark. Pharmacol Res Perspect. 2018;6(6):e00431.PubMedPubMedCentral
23.
Zurück zum Zitat Sirois C, Ouellet N, Reeve E. Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Adm Pharm. 2017;13(4):864–70. Sirois C, Ouellet N, Reeve E. Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Adm Pharm. 2017;13(4):864–70.
24.
Zurück zum Zitat Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24(6):570–5.PubMed Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract. 2007;24(6):570–5.PubMed
25.
Zurück zum Zitat Horner E, Fleming J, Studd J. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation. Climatcteric. 2006;9(6):459–63. Horner E, Fleming J, Studd J. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation. Climatcteric. 2006;9(6):459–63.
26.
Zurück zum Zitat Hopper I, de Silva C, Skiba M, Tonkin A, Krum H. Attitudes of patients and prescribing clinicians to polypharmacy and medication withdrawal in heart failure. J Card Fail. 2016;22(9):743–4.PubMed Hopper I, de Silva C, Skiba M, Tonkin A, Krum H. Attitudes of patients and prescribing clinicians to polypharmacy and medication withdrawal in heart failure. J Card Fail. 2016;22(9):743–4.PubMed
27.
Zurück zum Zitat Ng WL, Tan MZW, Koh EYL, Tan NC. Deprescribing: What are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community? Proc Singap Healthc. 2017;26(3):172–9. Ng WL, Tan MZW, Koh EYL, Tan NC. Deprescribing: What are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community? Proc Singap Healthc. 2017;26(3):172–9.
28.
Zurück zum Zitat Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract. 2001;18(6):597–601.PubMed Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract. 2001;18(6):597–601.PubMed
29.
Zurück zum Zitat Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017;65(12):2691–6.PubMedPubMedCentral Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017;65(12):2691–6.PubMedPubMedCentral
30.
Zurück zum Zitat Jia Hao L, Omar MS, Tohit N. Polypharmacy and willingness to deprescribe among elderly with chronic diseases. Int J Gerontol. 2018;12(4):340–3. Jia Hao L, Omar MS, Tohit N. Polypharmacy and willingness to deprescribe among elderly with chronic diseases. Int J Gerontol. 2018;12(4):340–3.
31.
Zurück zum Zitat Linsky A, Simon SR, Stolzmann K, Meterko M. Patient attitudes and experiences that predict medication discontinuation in the Veterans Health Administration. J Am Pharm Assoc (2003). 2018;58(1):13–20. Linsky A, Simon SR, Stolzmann K, Meterko M. Patient attitudes and experiences that predict medication discontinuation in the Veterans Health Administration. J Am Pharm Assoc (2003). 2018;58(1):13–20.
32.
Zurück zum Zitat Linsky A, Meterko M, Bokhour BG, Stolzmann K, Simon SR. Deprescribing in the context of multiple providers: Understanding patient preferences. Am J Manag Care. 2019;25(4):192–8.PubMedPubMedCentral Linsky A, Meterko M, Bokhour BG, Stolzmann K, Simon SR. Deprescribing in the context of multiple providers: Understanding patient preferences. Am J Manag Care. 2019;25(4):192–8.PubMedPubMedCentral
33.
Zurück zum Zitat Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14.PubMed Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14.PubMed
34.
Zurück zum Zitat Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc. 2019;67(6):1204–10.PubMed Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc. 2019;67(6):1204–10.PubMed
35.
Zurück zum Zitat Iliffe S, Curran HV, Collins R, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8(3):242–8.PubMed Iliffe S, Curran HV, Collins R, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8(3):242–8.PubMed
36.
Zurück zum Zitat Schöpf AC, Von Hirschhausen M, Farin E, Maun A. Elderly patients’ and GPs’ perspectives of patient-GP communication concerning polypharmacy: a qualitative interview study. Prim Health Care Res Dev. 2018;19(4):355–64.PubMed Schöpf AC, Von Hirschhausen M, Farin E, Maun A. Elderly patients’ and GPs’ perspectives of patient-GP communication concerning polypharmacy: a qualitative interview study. Prim Health Care Res Dev. 2018;19(4):355–64.PubMed
37.
Zurück zum Zitat Weir K, Nickel B, Naganathan V, Bonner C, McCaffery K, Carter SM, et al. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. J Gerontol B Psychol Sci Soc Sci. 2018;73(7):e98–107.PubMed Weir K, Nickel B, Naganathan V, Bonner C, McCaffery K, Carter SM, et al. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. J Gerontol B Psychol Sci Soc Sci. 2018;73(7):e98–107.PubMed
38.
Zurück zum Zitat Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMed Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMed
39.
Zurück zum Zitat Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. Med. 2007;22:1094–100. Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. Med. 2007;22:1094–100.
40.
Zurück zum Zitat Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98(2):220–5.PubMed Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98(2):220–5.PubMed
41.
Zurück zum Zitat Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. “I don’t know how many of these [medicines] are necessary..”—a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74(2):135–41.PubMed Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. “I don’t know how many of these [medicines] are necessary..”—a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74(2):135–41.PubMed
42.
Zurück zum Zitat Williams B, Shaw A, Durrant R, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM. 2005;98(12):885–93.PubMed Williams B, Shaw A, Durrant R, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM. 2005;98(12):885–93.PubMed
43.
Zurück zum Zitat Reeve E, Low L-F, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–60.PubMedPubMedCentral Reeve E, Low L-F, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–60.PubMedPubMedCentral
44.
Zurück zum Zitat Clyne B, Cooper JA, Boland F, Hughes CM, Fahey T, Smith SM, et al. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;67(660):e507–18.PubMedPubMedCentral Clyne B, Cooper JA, Boland F, Hughes CM, Fahey T, Smith SM, et al. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;67(660):e507–18.PubMedPubMedCentral
45.
Zurück zum Zitat Luymes CH, Boelhouwer NJ, Poortvliet RKE, de Ruijter W, Reis R, Numans ME. Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient Prefer Adherence. 2017;11:975–84.PubMedPubMedCentral Luymes CH, Boelhouwer NJ, Poortvliet RKE, de Ruijter W, Reis R, Numans ME. Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient Prefer Adherence. 2017;11:975–84.PubMedPubMedCentral
46.
Zurück zum Zitat McKillop G, Joy J. Patients’ experience and perceptions of polypharmacy in chronic kidney disease and its impact on adherent behaviour. J Ren Care. 2013;39(4):200–7.PubMed McKillop G, Joy J. Patients’ experience and perceptions of polypharmacy in chronic kidney disease and its impact on adherent behaviour. J Ren Care. 2013;39(4):200–7.PubMed
47.
Zurück zum Zitat Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35(1):51–6.PubMed Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35(1):51–6.PubMed
48.
Zurück zum Zitat Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatol. 2005;44(6):762–7. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatol. 2005;44(6):762–7.
49.
Zurück zum Zitat Bachinger SM, Kolk AM, Smets EM. Patients’ trust in their physician—psychometric properties of the Dutch version of the “Wake Forest Physician Trust Scale.” Patient Educ Couns. 2009;76(1):126–31.PubMed Bachinger SM, Kolk AM, Smets EM. Patients’ trust in their physician—psychometric properties of the Dutch version of the “Wake Forest Physician Trust Scale.” Patient Educ Couns. 2009;76(1):126–31.PubMed
50.
Zurück zum Zitat Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychom Res. 1999;47:555–67. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychom Res. 1999;47:555–67.
51.
Zurück zum Zitat Eidam A, Roth A, Lacroix A, Goisser S, Seidling HM, Haefeli WE, et al. Methods to assess patient preferences in old age pharmacotherapy—a systematic review. Patient Prefer Adherence. 2020;14:467–97.PubMedPubMedCentral Eidam A, Roth A, Lacroix A, Goisser S, Seidling HM, Haefeli WE, et al. Methods to assess patient preferences in old age pharmacotherapy—a systematic review. Patient Prefer Adherence. 2020;14:467–97.PubMedPubMedCentral
52.
Zurück zum Zitat Mangin D, Stephen G, Bismah V, Risdon C. Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open. 2016;6:e010903.PubMedPubMedCentral Mangin D, Stephen G, Bismah V, Risdon C. Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open. 2016;6:e010903.PubMedPubMedCentral
53.
Zurück zum Zitat Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB et al. Decision aids for people facing health treatment or screening decisions. Cochrane Syst Rev. 2017;4:CD001431. Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB et al. Decision aids for people facing health treatment or screening decisions. Cochrane Syst Rev. 2017;4:CD001431.
Metadaten
Titel
Patient values and preferences on polypharmacy and deprescribing: a scoping review
verfasst von
Evan Forest
Melissa Ireland
Uma Yakandawala
Teresa Cavett
Lalitha Raman-Wilms
Jamie Falk
Diana McMillan
Rhys Linthorst
Leanne Kosowan
Lisa Labine
Christine Leong
Publikationsdatum
22.09.2021
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2021
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01328-w

Weitere Artikel der Ausgabe 6/2021

International Journal of Clinical Pharmacy 6/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.